SecSonar.com

Aprea Therapeutics, Inc. (APRE)

Aprea Therapeutics, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Aprea Therapeutics, Inc. (APRE) is a Biotechnology company based in US with a market capitalization of $6.1M. Free cash flow was negative at -$12.9M. This page tracks APRE's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 8 employees · IPO Oct 3, 2019

Valuation

Valuation & price

$0.93 · as of May 17, 2026 · -55.3% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

0.49

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$1.93$1.26$0.59Jul 25Dec 25Jul 26Jul 7, 25$1.73Jul 9, 25$1.88Jul 11, 25$1.73Jul 15, 25$1.63Jul 17, 25$1.67Jul 21, 25$1.73Jul 23, 25$1.93Jul 25, 25$1.89Jul 29, 25$1.76Jul 31, 25$1.70Aug 4, 25$1.70Aug 6, 25$1.64Aug 11, 25$1.69Aug 13, 25$1.71Aug 15, 25$1.69Aug 19, 25$1.59Aug 21, 25$1.60Aug 25, 25$1.60Aug 27, 25$1.60Aug 29, 25$1.57Sep 3, 25$1.53Sep 5, 25$1.55Sep 9, 25$1.55Sep 11, 25$1.57Sep 16, 25$1.46Sep 18, 25$1.50Sep 22, 25$1.47Sep 24, 25$1.42Sep 26, 25$1.46Sep 30, 25$1.48Oct 2, 25$1.48Oct 6, 25$1.49Oct 8, 25$1.43Oct 10, 25$1.42Oct 14, 25$1.51Oct 16, 25$1.54Oct 21, 25$1.51Oct 23, 25$1.52Oct 27, 25$1.34Oct 29, 25$1.45Oct 31, 25$1.40Nov 4, 25$1.37Nov 6, 25$1.20Nov 10, 25$1.27Nov 12, 25$1.26Nov 14, 25$1.21Nov 18, 25$1.19Nov 20, 25$1.11Nov 25, 25$1.21Nov 28, 25$1.26Dec 2, 25$1.02Dec 4, 25$1.06Dec 8, 25$1.04Dec 10, 25$0.91Dec 12, 25$0.93Dec 16, 25$0.91Dec 18, 25$0.91Dec 22, 25$0.93Dec 24, 25$0.95Dec 29, 25$0.92Jan 2, 26$0.85Jan 6, 26$0.91Jan 8, 26$0.94Jan 12, 26$0.92Jan 14, 26$0.90Jan 16, 26$0.89Jan 21, 26$0.83Jan 23, 26$0.83Jan 27, 26$0.83Jan 29, 26$0.59Feb 2, 26$0.75Feb 4, 26$0.67Feb 9, 26$0.66Feb 11, 26$0.61Feb 13, 26$0.61Feb 18, 26$0.73Feb 20, 26$0.76Feb 24, 26$0.80Feb 26, 26$0.88Mar 2, 26$0.89Mar 4, 26$0.91Mar 6, 26$0.90Mar 10, 26$0.83Mar 12, 26$0.77Mar 17, 26$0.78Mar 19, 26$0.76Mar 23, 26$0.68Mar 25, 26$0.67Mar 27, 26$0.68Mar 31, 26$0.76Apr 2, 26$0.72Apr 7, 26$0.71Apr 9, 26$0.73Apr 13, 26$0.85Apr 15, 26$0.94Apr 17, 26$1.00Apr 22, 26$0.95Apr 24, 26$0.93Apr 28, 26$0.84Apr 30, 26$0.80May 4, 26$0.84May 6, 26$0.83May 8, 26$0.98May 12, 26$0.90May 14, 26$0.94May 18, 26$0.85May 20, 26$0.90May 22, 26$0.95May 28, 26$0.93Jun 1, 26$0.82Jun 3, 26$0.76Jun 5, 26$0.74Jun 9, 26$0.74Jun 11, 26$0.77Jun 15, 26$0.70Jun 17, 26$0.78Jun 22, 26$0.79Jun 24, 26$0.81Jun 26, 26$0.79Jul 2, 26$0.74
$0.5952-week range$2.08
Loading valuation history…

Fundamentals

Key fundamentals

$6.1M

Market cap

—

Revenue growth (YoY)

-523.2%

Gross margin

-$12.9M

Free cash flow (USD)

-$14.6M

Net debt

Net cash position

18.7%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2017 → 2025

FY 2017$0.00FY 2018$0.00FY 2019$0.00FY 2020$0.00FY 2021$0.00FY 2022$0.00FY 2023$583.2KFY 2024$1.5MFY 2025$0.00
$0$0

Free cash flow by year

2017 → 2025

FY 2017$-14.0MFY 2018$-15.3MFY 2019$-26.7MFY 2020$-41.8MFY 2021$-37.7MFY 2022$-25.0MFY 2023$-12.3MFY 2024$-13.6MFY 2025$-12.9M
-$14M-$12.9M

Gross margin by year

2023 → 2024

FY 202398.8%FY 2024-523.2%
98.8%-523.2%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 13, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventAnnual Meeting ResultsJun 17, 2026Filing
  • 8-K eventEarnings ReleaseMay 13, 2026Filing
  • Quarterly report10-Q FiledMay 13, 2026Filing
  • FinancingSecurities RegistrationApr 22, 2026Filing
  • 8-K eventPrivate Placement ClosingApr 1, 2026Filing

Questions

Frequently asked questions

What is Aprea Therapeutics, Inc.'s market cap?

Aprea Therapeutics, Inc. (APRE) has a market capitalization of $6.1M.

What is APRE's P/E ratio?

A meaningful P/E ratio is not available for APRE — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is APRE's price-to-book (P/B) ratio?

APRE trades at 0.49 times book value per share.

Are insiders buying APRE stock?

SEC Form 4 filings show no open-market insider buys at Aprea Therapeutics, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

EVGN

Evogene Ltd.

$6.1M

XBIO

Xenetic Biosciences, Inc.

$5.9M

CELZ

Creative Medical Technology Holdings, Inc.

$5.9M

RADX

Radiopharm Theranostics Limited

$5.8M

XTLB

XTL Biopharmaceuticals Ltd.

$5.7M

CUPR

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares

$6.7M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.